Latest news
KOSPI rebounds to 6,358.95, up 1.62%…KOSDAQ surges 5.88%, buy-side “sidecar” for 3 straight sessions - theconnectmoney.comtheconnectmoney.com · Tue, 04 Aug 2026 07:53:00 GMT2019 Kolon Life Science’s brief glory for Korea’s first gene therapy…then the company’s “ingredient” story differed [That Stock at That Time] - theconnectmoney.comtheconnectmoney.com · Mon, 03 Aug 2026 23:49:00 GMT2019 Kolon Life Science, the glory of the country’s first gene therapy... but the ingredients were different [That Stock Back Then] - theconnectmoney.comtheconnectmoney.com · Mon, 03 Aug 2026 23:49:00 GMT[Confusing Can Cost You] Samsung Biologics vs Samsung Epics Holdings: The Split Rule Between “Factory Utilization” and “New Drug Patents” - theconnectmoney.comtheconnectmoney.com · Sun, 02 Aug 2026 07:54:00 GMT